MY EXCHANGE WITH KELLY YESTERDAY ON THE BIEL SHAREHOLDERS PAGE.
————————————
ME-Kelly Whelan inform your father and the VP of sales, the lack of information in the wake of this monstrous decline in share price is absolutely unacceptable. Shareholders (and yes you included) deserve to know what is transpiring behind closed doors, and we also deserve a hard timeline of what has taken place, and will be taking place going forward. We need answers for the continued quarter after quarter losses, while BIEL keeps adding countries, which should result in gains, not losses. We need to know inventory, are there shortages of product, if yes when will this be rectified, if no, why is there not a big push to get it out there. Why has there been no advertising or marketing of the Feb 2017 FDA approved devices? Where is the migraine study at, and what is the timeframe there, as well as the female monthly device. Has the recent FDA denial been addressed, and has the company resubmitted or will it be resubmitted soon? All these questions should serve as a template for a PR about the current state of affairs at Biel. Thank you, and please I urge you to submit this to your father.
KW- you are aware there is a partial government shutdown that has affected the operations at the FDA?
ME-Kelly Whelan yes, what does that have to do with the 2017 approved devices, quarterly losses, VA, anticipated timeframes for POST-shutdown events, global markets where there is no shutdown,inventory, just to mention a few. Again.
—she did not reply—
